Patients in insulin analogues use via judicial litigation: do they use the Brazilian Public Health System (SUS)?

• Auteurs principaux: Thays Santos Mendonça (Auteur), Eduardo Sérgio Silva (Auteur), Mariana Linhares Pereira (Auteur), Paulo Roque Obreli-Neto (Auteur), Vinícius Silva Belo (Auteur), Gustavo Costa Ferreira (Auteur), Paula Resende Daher Chaves (Auteur), Silvana Nair Leite (Auteur), André Oliveira Baldoni (Auteur)
• Format: Livre
• Publié: Instituto de Estudos em Saúde Coletiva da Universidade Federal do Rio de Janeiro, 2023-05-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Abstract Background Studies show that among the drugs most commonly used in judicial litigation in Brazil, are those used to treat diabetes mellitus, especially insulin analogues. Objective Evaluate the use of the Unified Health System (SUS) by patients with type 1 diabetes mellitus (T1DM), who rece...